Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesTreatment options for recurrent glioblastoma: pitfalls and future trends
Expert Review of Anticancer Therapy, 05/19/09
Franceschi E et al. - Standard treatment with temozolomide and radiotherapy for patients with newly diagnosed glioblastoma has increased the median overall survival and, more importantly, the 2-year survival rate of patients. However, as yet, no investigations have been conducted to define effective strategies against recurrence, which occurs in most patients following combined radiotherapy/temozolomide treatment. Furthermore, in recent years, new issues have emerged regarding the evaluation of disease response, and also with the identification of patterns such as pseudoprogression, frequently indistinguishable from real disease progression. New therapeutic strategies, such as targeted therapies and anti-angiogenic treatments that appear promising with regard to improving the results at the time of recurrence are discussed.
Related Articles
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
British Journal of Cancer, 11/13/09
Relevance Score: 65%
Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09
Relevance Score: 65%
Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features
Child's Nervous System, 10/29/09
Relevance Score: 65%
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
BMC Cancer, 10/22/09
Relevance Score: 64%
Convection-enhanced delivery for the treatment of brain tumors
Expert Review of Neurotherapeutics, 10/21/09
Relevance Score: 64%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
Cancer, 12/14/09
Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
Critical Reviews in Oncology/Hematology, 12/14/09
Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas
Cancer Letters, 12/14/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results from the phase II EUR018 trial
Annals of Oncology, 12/15/09
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients
International Journal of Clinical Oncology, 12/15/09
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
International Journal of Clinical Oncology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor